Category
Clinical Practice
What actually happens at the point of care, and how far it sits from guidance. These stories cover practice patterns, clinician decision-making and the gap between evidence and delivery.
623 articles in this topic.
Articles in this category
10/19/2026
Adverse reaction reports in Portugal rise with GLP-1 use
Infarmed has logged 695 suspected adverse reactions to GLP-1 drugs in Portugal since 2024, most linked to Mounjaro.
Read Article →
10/19/2026
Foundayo Oral GLP-1 Tablet Gets Positive EU Opinion
The EMA's CHMP has backed Foundayo, a once-daily orforglipron tablet, for weight management and type 2 diabetes.
Read Article →
10/19/2026
EMA Draft Reflection Paper Sets Rules for Confirmatory Platform Trials
"EMA's draft reflection paper sets out how confirmatory platform trials should handle controls, randomisation, blinding and multiplicity. Comments are due 31 January 2027. #SyenzaNews #MarketAccess #ClinicalTrials"
Read Article →
10/19/2026
Reinforcement learning rTMS for depression treatment
Reinforcement learning rTMS for depression: a new npj Digital Medicine study tests protocol recommendations against clinician choices in 1,609 adults.
Read Article →
10/16/2026
AI operating room scheduling: LLM agent teams reach feasible plans
How can AI-powered scheduling transform operating room efficiency and deliver major cost savings?
Recent advancements are enabling hospitals to optimize resource allocation, reduce cancellations, and streamline workflows through intelligent automation.
Discover how this technology is reshaping surgical operations and improving financial outcomes.
#SyenzaNews #AIinHealthcare #HealthcareInnovation #ai #DigitalTransformation
Read Article →
10/15/2026
FDA Rare Disease Framework Initiative Would Tailor Review to Small Populations
What steps is the FDA taking to accelerate rare disease treatments?
The FDA’s new Rare Disease Framework Initiative aims to streamline regulatory pathways, enhance collaboration with sponsors, and improve patient access to innovative therapies.
Explore how this could reshape drug development for underserved patient populations.
#SyenzaNews #regulatoryaffairs #drugdevelopment #innovation #healthcarepolicy
Read Article →
10/15/2026
Semaglutide for Opioid Use Disorder: $13.3M Trial Planned in Allegheny County
Researchers and Allegheny County plan a $13.3 million trial of weekly semaglutide to reduce opioid and alcohol use and justice involvement.
Read Article →
10/15/2026
Social prescribing in Portugal: pilots, gaps and the cost of time
Social prescribing is not yet part of Portugal's national health system. Economists are asking whether it works, and who pays for it.
Read Article →
10/14/2026
BNT113 head and neck cancer trial misses first endpoint
BioNTech's AHEAD-MERIT trial did not reach significance on progression-free survival. The overall survival read-out is still to come.
Read Article →
10/14/2026
Denosumab Ascend Biosimilar Wins EU Authorisation for Bone Complications
The EMA has authorised Denosumab Ascend, a biosimilar of Xgeva. Here is what the assessment shows on safety, efficacy and use. #SyenzaNews #biotechnology #MarketAccess
Read Article →
10/13/2026
Individualised Genetic Therapies Test Regulation, Payment and HTA
OHE's A Dose of Economics explores why medicines made for one patient challenge regulation, payment and HTA.
Read Article →
10/12/2026
AI in Medical Education: Responsible Integration Across the Training Continuum
AI is entering every stage of medical training. A new npj Digital Medicine Perspective maps how to integrate it responsibly across UGME, GME and CME.
Read Article →